These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 26095525)

  • 1. Determinants of survival following pelvic exenteration for primary rectal cancer.
    Radwan RW; Jones HG; Rawat N; Davies M; Evans MD; Harris DA; Beynon J;
    Br J Surg; 2015 Sep; 102(10):1278-84. PubMed ID: 26095525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma.
    Gannon CJ; Zager JS; Chang GJ; Feig BW; Wood CG; Skibber JM; Rodriguez-Bigas MA
    Ann Surg Oncol; 2007 Jun; 14(6):1870-7. PubMed ID: 17406945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival after pelvic exenteration for T4 rectal cancer.
    Kusters M; Austin KK; Solomon MJ; Lee PJ; Nieuwenhuijzen GA; Rutten HJ
    Br J Surg; 2015 Jan; 102(1):125-31. PubMed ID: 25451182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer.
    PelvEx Collaborative
    Br J Surg; 2018 May; 105(6):650-657. PubMed ID: 29529336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pelvic exenteration for men with locally advanced rectal cancer: a morbidity analysis of complicated cases.
    Hsu TW; Chiang FF; Chen MC; Wang HM
    Asian J Surg; 2011 Jul; 34(3):115-20. PubMed ID: 22208686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer.
    Bhangu A; Ali SM; Brown G; Nicholls RJ; Tekkis P
    Ann Surg; 2014 Feb; 259(2):315-22. PubMed ID: 23478530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of pelvic exenteration for locally advanced primary rectal cancer: Overall survival and quality of life.
    Quyn AJ; Austin KK; Young JM; Badgery-Parker T; Masya LM; Roberts R; Solomon MJ
    Eur J Surg Oncol; 2016 Jun; 42(6):823-8. PubMed ID: 26947962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review of outcomes following pelvic exenteration for the treatment of primary and recurrent locally advanced rectal cancer.
    Platt E; Dovell G; Smolarek S
    Tech Coloproctol; 2018 Nov; 22(11):835-845. PubMed ID: 30506497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pelvic exenteration for advanced malignancy in elderly patients.
    Radwan RW; Evans MD; Davies M; Harris DA; Beynon J;
    Br J Surg; 2016 Jan; 103(2):e115-9. PubMed ID: 26662618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of pelvic exenteration for recurrent and primary locally advanced rectal cancer.
    Rottoli M; Vallicelli C; Boschi L; Poggioli G
    Int J Surg; 2017 Dec; 48():69-73. PubMed ID: 28987560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total pelvic exenteration for primary and recurrent malignancies.
    Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
    World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical and Survival Outcomes Following Pelvic Exenteration for Locally Advanced Primary Rectal Cancer: Results From an International Collaboration.
    PelvEx Collaborative
    Ann Surg; 2019 Feb; 269(2):315-321. PubMed ID: 28938268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical salvage of recurrent rectal cancer after transanal excision.
    Weiser MR; Landmann RG; Wong WD; Shia J; Guillem JG; Temple LK; Minsky BD; Cohen AM; Paty PB
    Dis Colon Rectum; 2005 Jun; 48(6):1169-75. PubMed ID: 15793645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pelvic Exenteration for Advanced Nonrectal Pelvic Malignancy.
    PelvExCollaborative
    Ann Surg; 2019 Nov; 270(5):899-905. PubMed ID: 31634184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life of survivors after pelvic exenteration for rectal cancer.
    Austin KK; Young JM; Solomon MJ
    Dis Colon Rectum; 2010 Aug; 53(8):1121-6. PubMed ID: 20628274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 10-year experience of total pelvic exenteration for primary advanced and locally recurrent rectal cancer based on a prospective database.
    Nielsen MB; Rasmussen PC; Lindegaard JC; Laurberg S
    Colorectal Dis; 2012 Sep; 14(9):1076-83. PubMed ID: 22107085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does radiotherapy of the primary rectal cancer affect prognosis after pelvic exenteration for recurrent rectal cancer?
    Rombouts AJ; Koh CE; Young JM; Masya L; Roberts R; De-Loyde K; de Wilt JH; Solomon MJ
    Dis Colon Rectum; 2015 Jan; 58(1):65-73. PubMed ID: 25489696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sacral resection with pelvic exenteration for advanced primary and recurrent pelvic cancer: a single-institution experience of 100 sacrectomies.
    Milne T; Solomon MJ; Lee P; Young JM; Stalley P; Harrison JD; Austin KK
    Dis Colon Rectum; 2014 Oct; 57(10):1153-61. PubMed ID: 25203370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Social deprivation in patients requiring pelvic exenterative surgery.
    Radwan RW; Coyne PE; Jones HG; Evans MD; Davies M; Harris DA; Beynon J
    Colorectal Dis; 2016 Jul; 18(7):684-7. PubMed ID: 26773422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended sacropelvic resection for locally recurrent rectal cancer: can it be done safely and with good oncologic outcomes?
    Colibaseanu DT; Dozois EJ; Mathis KL; Rose PS; Ugarte ML; Abdelsattar ZM; Williams MD; Larson DW
    Dis Colon Rectum; 2014 Jan; 57(1):47-55. PubMed ID: 24316945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.